MRONJ

Understanding and managing Medication-Related Osteonecrosis of the Jaw (MRONJ) is an essential component of contemporary dental care, especially relevant with increasing numbers of patients undergoing anti-resorptive or anti-angiogenic drug therapy.

MRONJ, a serious condition characterised by bone necrosis in the jaw, poses significant challenges in dental treatment and patient management.

This course is carefully designed to provide dental professionals with an in-depth understanding of MRONJ, focusing on the pathophysiology, risk factors, and clinical presentations of this complex condition.

We emphasise the importance of accurate risk assessment and developing individualised treatment plans, which are essential for the effective management of patients at risk of or suffering from MRONJ.

You will gain insights into the latest best practices and guidelines, equipping you with the necessary tools and knowledge to navigate the challenges posed by MRONJ.

This comprehensive course aims to enhance your clinical skills, improve patient outcomes, and strengthen your role as a essential part of the healthcare team in managing patients affected by MRONJ.

If you're not yet a member of Dentaljuce, we highly recommend you to join and gain access to our comprehensive course on MRONJ.

This course, along with over 100 other CPD courses, is available for a single membership payment.

Member Feedback on MRONJ Management for Dental Professionals

A really helpful module, thanks
Concise and highly relevant clinical insights.
Very practical advice for patient management.
Clear explanation of MRONJ risks and prevention

Your Professional Development Plan: Regulatory authorities recommend that CPD/CE is undertaken based on learning needs that you have identified and entered into your PDP. Some authorities may not accept your CPD as verifiable unless it has been identified in the PDP before you undertake it.

Here is an example, using the GDC's recommended format, for a PDP entry for this course.

PDP Learning or Maintenance need

Understanding and managing MRONJ in patients under anti-resorptive or anti-angiogenic drug therapy

How does this relate to my field of practice?

As a dental professional, I frequently encounter patients under these drug therapies. Understanding MRONJ and its management is very important for providing optimal care.

Which GDC development outcome(s) does it link to?

A B C D

What benefit will this have to my work?

By enhancing my knowledge on MRONJ, I can:

Provide accurate risk assessment and tailored treatment approaches for patients.
Apply current best practices and guidelines in managing patients at risk of MRONJ.
Ensure comprehensive documentation in the clinical notes, improving patient care and legal compliance.

How will I meet this learning or maintenance need?

I will complete the Dentaljuce module on 'MRONJ Management', which covers the pathophysiology, risk assessment, and management strategies. I will also seek feedback from peers and engage in self-assessment to ensure my understanding and application of the knowledge.

When will I complete this by?

2025

PDP Learning or Maintenance need

Understanding and managing MRONJ

How does this relate to my field of practice?

Very important for patient care under specific drug therapies.

Which GDC development outcome(s) does it link to?

A B C D

What benefit will this have to my work?

Improved patient care, risk assessment, and legal compliance.

How will I meet this learning or maintenance need?

Complete Dentaljuce's 'MRONJ Management' module and engage in peer feedback.

When will I complete this by?

2025

MRONJ Management for Dental Professionals

This online learning course has clear and concise aims, objectives and anticipated outcomes, listed below. These will appear on the Dentaljuce Enhanced CPD Certificate, along with the time spent, dates, and detailed topics you studied within the module. Certificates can be printed at any time, covering any range of dates. Dentaljuce CPD complies with the UK GDC's requirements for enhanced verifiable continuing professional development.

Aim:

The aim of this Dentaljuce module is to enhance dental professionals' understanding and management skills regarding patients at risk of MRONJ, focusing on the identification, risk assessment, and tailored treatment approaches for patients under anti-resorptive or anti-angiogenic drug therapy.

Objective:

To provide an in-depth understanding of MRONJ, including its definition, pathophysiology, and association with anti-resorptive and anti-angiogenic drugs.
To develop competence in risk assessment, classification, and evidence-based management strategies for patients at risk of MRONJ.

Anticipated learning outcomes:

The learner will:

Be able to accurately define MRONJ and describe its pathophysiology, particularly in relation to anti-resorptive and anti-angiogenic drugs.
Gain knowledge on the various anti-resorptive and anti-angiogenic drugs, understanding their mechanisms and how they contribute to the risk of MRONJ.
Be adept at assessing and classifying patients' risk levels for developing MRONJ, incorporating factors such as type and duration of drug therapy.
Develop skills in the initial and continuing management of patients at risk of MRONJ, applying current best practices and guidelines.
Understand the significance of comprehensive documentation in the clinical notes, including risk assessment outcomes and management plans for patients at risk of MRONJ.

GDC Outcomes: A,B,C,D

Participant Feedback Review: MRONJ

Overall Participant Impression

Participants provided consistently positive feedback on the "MRONJ" course, highlighting its concise and practical approach to a complex clinical topic. The course effectively enhanced understanding of MRONJ, improved confidence in patient risk assessment, and offered clear, clinically relevant guidelines for patient management.

Key Strengths

Participants particularly appreciated:

Clear and concise explanations of MRONJ, its pathophysiology, and associated risks.
Practical and relevant insights into patient management and prevention strategies.
Comprehensive coverage of anti-resorptive and anti-angiogenic drugs, with a strong emphasis on risk assessment and clinical documentation.
Inclusion of examples and photographs to illustrate key concepts effectively.

Specific Positive Comments:

"Really good course. Definitely made me more aware of the risks and management of these patients."
"Concise and highly relevant clinical insights."
"Excellent. I felt this course provided all the information I required from understanding the risk to patient management and record keeping."
"Great course content, examples, photos, and brief notes too."
"Very practical advice for patient management."
"Clear explanation of MRONJ risks and prevention."
"Concise and topical."
"A really helpful module, thanks."
"Excellent."

Areas for Improvement

Participants made minor suggestions for enhancing the module:

Providing additional detailed information on the specific management of dental extractions.

Closed-Question Feedback Summary:

Met learning objectives: 100% strongly agree/agree
Good quality: 100% strongly agree/agree
Useful & relevant: 100% strongly agree/agree
Engaging: 88.9% strongly agree/agree, 11.1% neutral
Pitched at right level: 100% strongly agree/agree

These results confirm high participant satisfaction, with unanimous endorsement of the course’s quality, relevance, and appropriate level of content.

Conclusion

Overall, the "MRONJ" course was very positively reviewed by participants as a concise, informative, and practical CPD module. It effectively supported dental professionals in understanding MRONJ, assessing patient risk, and managing clinical care confidently. The minor suggestion for further details on specific extraction guidelines could further enrich the course.

Script container

Aim
The aim of this Dentaljuce module is to enhance dental professionals' understanding and management skills regarding patients at risk of MRONJ, focusing on the identification, risk assessment, and tailored treatment approaches for patients under anti-resorptive or anti-angiogenic drug therapy.

Course objective

To provide an in-depth understanding of MRONJ, including its definition, pathophysiology, and association with anti-resorptive and anti-angiogenic drugs.
To develop competence in risk assessment, classification, and evidence-based management strategies for patients at risk of MRONJ.

Anticipated learning outcomes:

The learner will:

Be able to accurately define MRONJ and describe its pathophysiology, particularly in relation to anti-resorptive and anti-angiogenic drugs.
Gain knowledge on the various anti-resorptive and anti-angiogenic drugs, understanding their mechanisms and how they contribute to the risk of MRONJ.
Be adept at assessing and classifying patients' risk levels for developing MRONJ, incorporating factors such as type and duration of drug therapy.
Develop skills in the initial and continuing management of patients at risk of MRONJ, applying current best practices and guidelines.
Understand the significance of comprehensive documentation in the clinical notes, including risk assessment outcomes and management plans for patients at risk of MRONJ.

GDC Development Outcomes
This CPD will support the learner in meeting the following GDC Development Outcome(s): A B C D.

View Outcomes Mapping

Next: Understanding MRONJ

This content is only available to members

Login

Forgot your password?